Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2023-11-17 History
Report ID 81686
Drug Identification Number 02398427
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 20ml
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-25
Estimated end date Unknown
Actual end date 2023-07-07
Shortage status Resolved
Updated date 2023-11-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-15 English Compare
v2 2019-04-15 French Compare
v3 2019-04-18 English Compare
v4 2019-04-18 French Compare
v5 2019-11-06 English Compare
v6 2019-11-06 French Compare
v7 2019-11-19 English Compare
v8 2019-11-19 French Compare
v9 2019-12-05 English Compare
v10 2019-12-05 French Compare
v11 2019-12-06 English Compare
v12 2019-12-06 French Compare
v13 2020-06-08 English Compare
v14 2020-06-08 French Compare
v15 2021-03-08 English Compare
v16 2021-03-08 French Compare
v17 2023-11-17 English Compare
v18 2023-11-17 French Compare

Showing 1 to 18 of 18